Cost-effectiveness of metered-dose inhalers for asthma exacerbations in the Pediatric Emergency Department

Pediatrics

Volumn 127, Issue 5, 2011, Pages

  Doan, Quynh ^a   Shefrin, Allan ^a   Johnson, David ^b,c  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b ALBERTA CHILDREN'S HOSPITAL   (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

Author keywords

agonist; Asthma; Cost effectiveness; Metered dose inhalers; Nebulizers

Indexed keywords

IPRATROPIUM BROMIDE; SALBUTAMOL;

ARTICLE; ASTHMA; CHILD; COCHRANE LIBRARY; CONTROLLED STUDY; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DISEASE EXACERBATION; DRUG COST; DRUG DOSAGE FORM COMPARISON; DRUG DOSE COMPARISON; DRUG EFFICACY; HEALTH CARE COST; HEALTH CARE UTILIZATION; HOSPITAL COST; HUMAN; INHALATION SPACER; MEDICAL NEBULIZER; METERED DOSE INHALER; NEBULIZER; PEDIATRIC WARD; PRIORITY JOURNAL; PROBABILITY; SENSITIVITY ANALYSIS; TREATMENT OUTCOME;

ADMINISTRATION, INHALATION; ADOLESCENT; ALBUTEROL; ASTHMA; BRITISH COLUMBIA; CHILD; CHILD, PRESCHOOL; COST SAVINGS; COST-BENEFIT ANALYSIS; DECISION SUPPORT TECHNIQUES; EMERGENCY SERVICE, HOSPITAL; EMERGENCY TREATMENT; FEMALE; HUMANS; MALE; METERED DOSE INHALERS; MONTE CARLO METHOD; NEBULIZERS AND VAPORIZERS; RECURRENCE; SEVERITY OF ILLNESS INDEX;

EID: 79955499377     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2010-2963     Document Type: Article

References (13)

1. Akinbami LJ, Moorman JE, Garbe PL, Sondik EJ. Status of childhood asthma in the United States, 1980 -2007. Pediatrics. 2009; 123(suppl 3):S131-S145
2. Statistics Canada. National Population Health Survey 1996/97. Available at: www.statcan.gc.ca/ cgi-bin/imdb/p2SV.pl?Function=getSurvey& SurvId=19819&SurvVer=1&InstaId= 20083&InstaVer=2&SDDS= 5003&lang= en&db=imdb&adm=8&dis=2. Accessed March 3, 2009
3. Becker A, Bérubé D, Chad Z, et al. Canadian Pediatric Asthma Consensus guidelines, 2003 (updated to December 2004): introduction. CMAJ. 2005;173(6 suppl):S12-S14
4. Becker A, Lemière C, Bérubé D, et al; Asthma Guidelines Working Group of the Canadian Network For Asthma Care. Summary of recommendations from the Canadian Asthma Consensus guidelines, 2003. CMAJ. 2005; 173(6 suppl):S3-S11
5. Cates CJ, Crilly JA, Rowe BH. Holding chambers (spacers) versus nebulisers for beta-agonist treatment of acute asthma. Cochrane Database Syst Rev. 2006;(2): CD000052
6. Osmond MH, Gazarian M, Henry RL, Clifford TJ, Tetzlaff J; PERC Spacer Study Group. Barriers to metered-dose inhaler/spacer use in Canadian pediatric emergency departments: a national survey. Acad Emerg Med. 2007;14(11):1106-1113
7. Leversha AM, Campanella SG, Aickin RP, Asher MI. Costs and effectiveness of spacer versus nebulizer in young children with moderate and severe acute asthma. J Pediatr. 2000;136(14):497-502 (Pubitemid 30469591)
8. British Columbia Ministry of Health Services. Medical services commission payment schedule, emergency medicine. Available at: www.health.gov.bc.ca/msp/ infoprac/physbilling/payschedule/index. html. Accessed April 10, 2009
9. Claxton K. The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies. J Health Econ. 1999;18(3):341-364 (Pubitemid 29242816)
10. Everard ML, Bara A, Kurian M, Elliott TM, Ducharme F, Mayowe V. Anticholinergic drugs for wheeze in children under the age of two years. Cochrane Database Syst Rev. 2005;(3):CD001279
11. Plotnick LH, Ducharme FM. Combined inhaled anticholinergics and beta2-agonists for initial treatment of acute asthma in children. Cochrane Database Syst Rev. 2000;(2): CD000060
12. Dotson K, Dallman M, Bowman CM, Titus MO. Ipratropium bromide for acute asthma exacerbations in the emergency setting: a literature review of the evidence. Pediatr Emerg Care. 2009;25(10):687-692
13. Everard M, Bara A, Kurian M, N'Diaye T, Ducharme F, Mayowe V. Anticholinergic drugs for wheeze in children under the age of two years. Cochrane Database of Systematic Reviews 2005, Issue 3. Art. CD001279. doi: 10.1002/ 14651858.CD001279.pub2